文献速递骨质疏松与代谢性骨病骨肿瘤创伤骨科

癌症患者的骨折与长期死亡率:一项基于人群的队列研究

Fractures and long-term mortality in cancer patients: a population-based cohort study.
PubMed 文献 · Osteoporos Int · 2022-08-29

该研究基于加拿大曼尼托巴省122,045例癌症患者数据,评估骨折与全因死亡率的关系。除前臂外,各部位骨折均与死亡率风险增加相关,骨折后第一年超额风险最大(HR 2.42,95%CI 2.30-2.54),且持续超过5年(HR 1.60,95%CI 1.50-1.70)。

要点

  • 癌症患者发生主要骨折(髋部、椎体、肱骨、前臂)与全因死亡率增加相关,但前臂骨折除外。
  • 骨折后第一年死亡风险最高(HR 2.42,95%CI 2.30-2.54),5年后仍显著(HR 1.60,95%CI 1.50-1.70)。
  • 癌症诊断10年后发生的骨折仍与死亡风险增加相关(HR 1.93,95%CI 1.79-2.07)。

核心结论

  • 癌症患者的骨折与全因死亡率增加相关,骨折后第一年超额风险最大,并持续超过5年;癌症诊断10年后及以后发生的骨折风险也增加。

研究设计与样本

  • 基于人群的队列研究,利用加拿大曼尼托巴省癌症登记处数据,纳入1987年1月1日至2014年3月31日诊断的122,045例癌症患者(中位年龄68岁,IQR 58-77,49.2%女性),随访至2015年3月31日。

主要发现

  • 中位随访5.8年期间,确诊主要骨折7,120例(5.8%)。
  • 除前臂外,所有骨折部位均与死亡率风险增加相关,多变量调整后仍显著。
  • 主要骨折后第一年全因死亡HR为2.42(95%CI 2.30-2.54),骨折后超过5年HR为1.60(95%CI 1.50-1.70)。
  • 癌症诊断超过10年后发生的骨折HR为1.93(95%CI 1.79-2.07)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We assessed post-fracture mortality in a population-based cohort of 122,045 individuals with cancers. Major fractures (hip, vertebrae, humerus, and forearm) were associated with early and long-term increased all-cause mortality. INTRODUCTION: Currently, there are no population-based data among cancer patients on post-fracture mortality risk across a broad range of cancer diagnoses. Our objective was to estimate the association of fracture with mortality in cancer survivors. METHODS: Using Manitoba Cancer Registry data from the province of Manitoba, Canada, we identified all women and men with cancer diagnosed between January 1, 1987, and March 31, 2014. We then linked cancer data to provincial healthcare administrative data and ascertained fractures after cancer diagnosis and mortality to March 31, 2015. Hazard ratios for all-cause mortality in those with versus without fracture were estimated from time-dependent Cox proportional hazards models adjusted for multiple covariates. RESULTS: The study cohort consisted of 122,045 cancer patients (median age 68 years, IQR 58-77, 49.2% female). During the median follow-up of 5.8 years from cancer diagnosis, we ascertained 7120 (5.8%) major fractures. All fracture sites, except for the forearm, were associated with increased mortality risk, even after multivariable adjustment. Excess mortality risk associated with a major fracture was greatest in the first year after fracture (HR 2.42, 95% CI 2.30-2.54) and remained significant > 5 years after fracture (HR 1.60, 95% CI 1.50-1.70) and for fractures occurring > 10 years after cancer diagnosis (HR 1.93, 95% CI 1.79-2.07). CONCLUSION: Fractures among cancer patients are associated with increased all-cause mortality. This excess risk is greatest in the first year and persists more than 5 years post-fracture; increased risk is also noted for fractures occurring up to and beyond 10 years after cancer diagnosis.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Ye C, Leslie WD, Al-Azazi S, et al. Fractures and long-term mortality in cancer patients: a population-based cohort study. Osteoporos Int. 2022. PMID: 36036268. doi:10.1007/s00198-022-06542-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。